Founded in the year 1996, Dr. A Velumani, a BARC scientist turned entrepreneur, fathered Thyrocare. Thyrocare Technologies Limited has emerged to be the biggest leader and a trendsetter in the Indian Diagnostic Industry. It spans over 1000 plus dedicated service providers across India who cater to the diagnostic needs of end user and small laboratories who outsource the high-end tests to Thyrocare.
Focused on metabolic chronic disorders, Thyrocare works on intelligently packaged preventive care profiles.
Today, the rise in health calamities due to changing lifestyle has inspired the company to make preventive healthcare as its prime focus! Embracing a test menu of over 200 tests under different technologies, to detect the ever rising health issues; Thyrocare operates with a 24x7 functional Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory (RPL) in major metro cities of India and other parts of Asia.
The laboratory automation Aptio, a unified solution for pre-analytical, analytical and post-analytical phases, has the capacity to handle 100,000 samples every day. With an error-free processing, around Currently it handles 50,000 samples every day with over 200,000 investigations every night, before midnight and only in night. This is ably supported with its unmatched speed with a synchrony of Air cargo logistics and barcoded, bi-directional systems connecting the country to its laboratory seamlessly.
Along with technologies, automation and tests, Quality remained the heart of Thyrocare right from its inception. The laboratory got accredited by ISO 9001:2001 which has now escalated to ISO 9001:2008, NABL in 2005 and CAP (College of American Pathologists) in 2007.
Our Major Strengths
Quality, Cost, Speed, Reach, Systems and Focus
Specialties:
Thyroid, Diabetes, Anemia, Arthritis, Cancer, Infertility, Pregnancy, Preventive Healthcare, Diagnostic Laboratory, PET-CT Scan
Focused on metabolic chronic disorders, Thyrocare works on intelligently packaged preventive care profiles.
Today, the rise in health calamities due to changing lifestyle has inspired the company to make preventive healthcare as its prime focus! Embracing a test menu of over 200 tests under different technologies, to detect the ever rising health issues; Thyrocare operates with a 24x7 functional Centralized Processing Laboratory (CPL) in Mumbai - India for esoteric tests; and Regional Processing Laboratory (RPL) in major metro cities of India and other parts of Asia.
The laboratory automation Aptio, a unified solution for pre-analytical, analytical and post-analytical phases, has the capacity to handle 100,000 samples every day. With an error-free processing, around Currently it handles 50,000 samples every day with over 200,000 investigations every night, before midnight and only in night. This is ably supported with its unmatched speed with a synchrony of Air cargo logistics and barcoded, bi-directional systems connecting the country to its laboratory seamlessly.
Along with technologies, automation and tests, Quality remained the heart of Thyrocare right from its inception. The laboratory got accredited by ISO 9001:2001 which has now escalated to ISO 9001:2008, NABL in 2005 and CAP (College of American Pathologists) in 2007.
Our Major Strengths
Quality, Cost, Speed, Reach, Systems and Focus
Specialties:
Thyroid, Diabetes, Anemia, Arthritis, Cancer, Infertility, Pregnancy, Preventive Healthcare, Diagnostic Laboratory, PET-CT Scan
Location: India, Maharashtra, Navi Mumbai
Employees: 1001-5000
Phone: +91 22 3090 0000
Founded date: 1996
Investors 2
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
| - | Nalanda Ca... | nalandacap... |
Mentions in press and media 42
| Date | Title | Description |
| 17.08.2026 | PharmEasy Claims To Be Debt Free After Paring More Stake In Thyrocare | SUMMARY Thyrocare promoter Docon Technologies sold 1.58 Mn Thyrocare shares, representing around 9.90% of the company’s paid-up equity share capital, via open market trades. The repayment removes the debt-linked encumbrance from Docon’s 51.... |
| 09.07.2026 | BAAS Technologies, Avni Wellness, SAVE Microfinance raise funds; BlackSoil inks M&A | Credit: 123RF.com Feminine hygiene brand Avni Wellness and spacetech startup BAAS Technologies have bagged funding in early-stage rounds, while SAVE Microfinance has raised debt to support its expansion. Separately,alternative credit platfo... |
| 04.06.2026 | Simple Energy Accelerates Growth with Rs 250 Cr Boost, Targets Mass Market & FY28 IPO | Simple Energy, a prominent Indian electric two-wheeler maker, just secured Rs 250 crore in crucial Series B funding. This significant capital infusion will supercharge manufacturing capacity and dramatically expand its nationwide retail pre... |
| 01.06.2026 | EV maker Simple Energy bags $26 mn, sets sights on FY28 listing | Suhas Rajkumar, founder and CEO, Simple Energy Bengaluru-based electric two-wheeler maker Simple Energy has raised Rs 250 crore ($26.3 million) through a mix of equity and debt, closing its Series B funding round. The round comprised Rs 123... |
| 01.06.2026 | EV-maker Simple Energy raises Rs 250 crore, eyes IPO in FY28 second half | Synopsis Bengaluru-based Simple Energy has secured Rs 250 crore in funding to boost manufacturing capacity and expand its retail network. The electric two-wheeler maker plans to increase production significantly and aims for an IPO in the s... |
| 15.05.2026 | Exclusive: EV Startup Simple Energy To Raise ₹127 Cr | SUMMARY Simple Energy is raising ₹126.7 Cr in a round led by existing backer Thyrocare founder Arokiaswamy Velumani Cofounders Suhas Rajkumar and Ankit Gupta will infuse ₹13.5 Cr each in the EV startup The funding comes at a time when the E... |
| 25.10.2025 | PharmEasy Sells 10% Stake In Thyrocare For INR 668 Cr | SUMMARY PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal The company raked in a total of INR 667.7 Cr share via the block deal, which valued ea... |
| 15.10.2025 | Q2 Results Highlights: IRFC, HDFC AMC Q2 profit rise, Axis Bank Q2 profit declines, HBD Financial, KEI Ind, Angel One, L&T finance to announce Q2 results, BoM, Persistent Systems & ICICIGI sha... | Q2 Results October 15, 2025 highlight: Find all the latest Q2 results 2025 updates of Axis Bank, Indian Railway Finance Corporation, HDFC Life Insurance Company, HDFC Asset Management Company, L&T Finance, HDB Financial Services, Oberoi... |
| 14.10.2025 | PharmEasy-Owned Thyrocare’s Q2 Profit Zooms 81% YoY To INR 48 Cr | SUMMARY On a sequential basis, the company's profit grew 25% from INR 38.3 Cr The company's operating revenue stood at INR 216.5 Cr during Q2 FY26, up 22% YoY and 12% QoQ Its total expenses rose 10% YoY and 7% QoQ to INR 157.3 Cr --> FOL... |
| 14.10.2025 | Q2 Results Highlights: BoM, Persistent Systems, ICICI Prudential & IREDA Q2 profit up, Aditya Birla Money profit declines, Tech Mahindra, ICICIGI to announce Q2 results | Q2 Results October 14, 2025 Highlights: Find all the latest Q2 results 2025 updates of Tech Mahindra, ICICI Lombard General Insurance Company, Automobile Corp of Goa, Persistent Systems, Bank of Maharashtra, Indian Renewable Energy Developm... |
Show more